INSIGHTS ON DRUG DEVELOPMENT
-
Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development
Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.
-
Strategies For The Development Of Safe And Effective Pediatric Formulations
Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
-
Take The Wheel And Drive Your Oligo Synthesis Where You Want
Explore the evolving oligo therapeutic landscape while identifying common challenges of bringing production in‑house and the key factors that shape long‑term success for smoother scale‑up.
-
Cost And Scalability Key Drivers Of Expanded Gene Therapy Access
Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.
-
Ultra-Low Cross-Linked Microgel Purification2/24/2026
ULC microgel purification is often slowed by linear polymer contamination and limitations of centrifugation. Explore how hollow fiber TFF improves filtration efficiency and supports scalable processing.
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems4/4/2025
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
Simplifying Antibody-Drug Conjugate Payload Synthesis8/5/2025
ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.
-
mRNA Vaccines And Therapeutics: Current Trends And Perspectives2/25/2025
Delve into the advancements and transformative impact of mRNA vaccine technology on modern medicine and explore how this technology is revolutionizing healthcare for the future and beyond.
-
Studying The Spatial Architecture Of Glioblastoma3/24/2025
Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).
DRUG DEVELOPMENT SOLUTIONS
-
Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.
-
Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.
-
For more than 30 years Curia has been meeting the custom synthesis needs of our clients.
-
Accelerate your path to market with integrated support to streamline processes, reduce delays, and deliver safe, user-friendly drug-delivery solutions.
-
The addition of global Sterile Fill-Finish and extensive lyophilization capabilities ensures that we are able to build on our enviable reputation and deliver on our promise of delivering life-changing therapies to patients worldwide.